PD-1 Inhibitor Improves Outcomes in NHL Subtype PD-1 Inhibitor Improves Outcomes in NHL Subtype
Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Health | Hematology | Lymphoma | Non-Hodgkin's Lymphoma | Radiation Therapy